- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02891473
A Rehabilitative Approach in Patients With Parkinson's Disease
July 3, 2017 updated by: Teresa Paolucci, University of Roma La Sapienza
Impact of Mézières Rehabilitative Method in Patients With Parkinson's Disease: a Randomized Controlled Trial
The purpose of the study is to evaluate the effectiveness of a rehabilitative approach using breathing and relaxation techniques, and specifically the elongation of the latissimus dorsi muscle according to the Mézières Method to improve balance and posture and relief pain in patients with Parkinson's disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rome, Italy, 00165
- Umberto I Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis od idiopathic Parkinson's disease (according to UK Brain Bank Criteria), Hoehn-Yahr stage ≤3 (determined during "on phase"), Mini Mental State Examination (MMSE) > or = 27, no rehabilitation treatment carried out within 3 months prior to the study, diagnosis of Parkinson's disease by at least 5 years.
Exclusion Criteria:
- Dyskinesias
- Severe fluctuations "on-off"
- Modifications of anti-Parkinsonian drug therapy during the three months prior to the start of the study)
- Sensitivity deficit of the trunk or lower extremities (physical examination)
- Vestibular disorders or paroxysmal vertigo
- Previous thoracic or abdominal surgery
- Other neurological or orthopedic conditions involving the trunk or lower extremities (musculoskeletal diseases, severe osteoarthritis, peripheral neuropathy, prosthetic surgery)
- Cardiovascular comorbidities (recent myocardial infarction, heart failure, uncontrolled hypertension, orthostatic hypotension)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mézières Method group
Sessions of exercises for the recovery of midline symmetry, diaphragmatic breathing exercises, stretching of the latissimus dorsi respecting the global elongation according to the Mézières Method.
|
10 sessions of rehabilitative treatment according to the Mézières Method, 2 sessions per week for 5 weeks, each lasting 1 hour.
|
Active Comparator: Home based exercise program group
Sessions of home based exercises performed by the patients at their domicile after a training session about the exercise program made by a physiotherapy.
The exercises aimed at promoting trunk control in static and dynamic position according to the specific guidelines for Parkinson's disease and proprioceptive exercises for the recovery of balance.
An illustrated exercises booklet was given to the patient.
|
1 single training session lasting 1 hour for the explication of the rehabilitation program that the patient has to perform independently at home followed by 2 sessions of home based exercises per week for 5 weeks, each lasting 1 hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Berg Balance Scale (BBS) from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
It is a widely used clinical tests to evaluate static and dynamic balance of a subject.
The total score is 56 (> 45 safe walking without aids/low tendency to fall, > 35 safe walking with aids).
The test lasts 15-20 minutes, and includes 14 simple tasks.
The success in achieving each task is evaluated assigned a score from zero (dependent) to four (independent), and the final measure is the sum of all scores.
The scale is considered the gold standard for providing useful information on the predictive estimation of the risk of falls.
|
Baseline, 4 weeks, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Visual Analogue Scale (VAS) from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
It is a scale for the assessment of pain and it's based on a ten point scale, where 0 means no pain and 10 the greatest pain ever both at rest and during movements.
|
Baseline, 4 weeks, 12 weeks
|
Change of Unified Parkinson's Disease Rating Scale (UPDRS) from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
It consists of six parts made up of questions about the mental state, behavior and mood, ADL, motor functions, the complications of the advanced disease, the stage of the disease identified by the Hoehen and Yahr scale and the modification in the execution of the ADL trough the scale of Schwab and England.
The scale is based on a metric scale from 0 (no disability) to 147 points (severe disability).
|
Baseline, 4 weeks, 12 weeks
|
Change of Functional Gait Assessment (FGA) from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
It is a 10-items scale that measures walking balance activity and it was developed from the Dynamic Gait Index (DGI) to improve reliability and decrease the ceiling effect.
Each item is scored on a 3 point-scale from 0 (severe impairment) to 3 (normal deambulation).
The highest possible score is 30 (normal gait function).
|
Baseline, 4 weeks, 12 weeks
|
Change of Clinical Evaluation of Posture from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
It is the evaluation of the anterior flexion of the trunk by measuring the distance fingers-floor.
|
Baseline, 4 weeks, 12 weeks
|
Change of Modified Parkinson Activity Scale (MPAS) from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
consists of 14 items arranged into three domains, chair transfer, gait akinesia and bed mobility.
Scores range from 0 (dependent) to 4 (normal) and the total possible score is 56.
|
Baseline, 4 weeks, 12 weeks
|
Change of SF-36 Health Survey Questionnaire from baseline to 12 weeks
Time Frame: Baseline, 4 weeks, 12 weeks
|
It is a multi-dimensional questionnaire for the evaluation of health status.
It is divided into eight sub-categories that measure physical activity, limitations due to physical health and emotional state, physical pain, the perception of general health, vitality, social activities, mental health and changes in health status and two indices that summarize the overall assessment of the subject with respect to his/her physical (ISF) and mental (ISM) health.
|
Baseline, 4 weeks, 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Vincenzo Maria Saraceni, Sapienza University of Rome, Policlinico Umberto I Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2015
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
August 31, 2016
First Submitted That Met QC Criteria
August 31, 2016
First Posted (Estimate)
September 7, 2016
Study Record Updates
Last Update Posted (Actual)
July 6, 2017
Last Update Submitted That Met QC Criteria
July 3, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2519/15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Neurocrine BiosciencesVoyager TherapeuticsCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia DiseaseUnited States
-
Second Affiliated Hospital of Soochow UniversityShanghai Regenelead Therapies Co., Ltd.RecruitingAdvanced Parkinson's DiseaseChina
-
AbbVieRecruitingParkinson's Disease (PD)Germany, Denmark, Spain
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Hubert FernandezRecruitingParkinson's Disease, IdiopathicUnited States
Clinical Trials on Mézières Method
-
Universidad Católica San Antonio de MurciaCompletedLow Back Pain | Postural; Strain
-
University of North Carolina, Chapel HillWithdrawn
-
Istanbul UniversityRecruitingAmelogenesis Imperfecta | Dental Age EstimationTurkey
-
Firat UniversityNot yet recruitingPain | Child Development | Nursing CareTurkey
-
JSI Research & Training Institute, Inc.UnknownWasting | Severe Acute Malnutrition
-
Dr. Behcet Uz Children's HospitalRecruitingAcute Respiratory Distress Syndrome | Acute Respiratory Failure | Pediatric Acute Respiratory Distress Syndrome (PARDS)Turkey
-
Indonesia UniversityCompletedPremature | Feeding; Difficult, NewbornIndonesia
-
Assistance Publique - Hôpitaux de ParisURC-ECO Clinical trial unit on health Economics, Hotel-Dieu Hospital; EA 7334...Unknown
-
Centre Hospitalier Universitaire DijonUnknownElderly People | Food Intake MeasurementFrance
-
Instituto de Investigación Sanitaria AragónBIT BEAUTY SL.CompletedStress, Physiological | Mood | Self Esteem | Psychological Well-beingSpain